×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
The past three years for VITA 34 (ETR:V3V) investors has not been profitable
Yahoo Finance UK
Every investor on earth makes bad calls sometimes. But really bad investments should be rare. So spare a thought for...
2 days ago
VITA 34 Full Year 2023 Earnings: EPS Beats Expectations
Simply Wall Street
VITA 34 ( ETR:V3V ) Full Year 2023 Results Key Financial Results Revenue: €77.1m (up 12% from FY 2022). Net loss...
1 month ago
Top 4 Cord Blood Companies to Invest In (May 2024)
Securities.io
Securities.io is not an investment adviser, and this does not constitute investment advice, financial advice, or trading advice.
13 months ago
Stem cell express
DW
Umbilical cord stems cells may hold the key to treating diseases like cancer and diabetes but preparing the cells for treatment is tricky.
158 months ago